Citius Oncology, Inc.

Market Cap

$74M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$0.69-$0.39 (-36.22%)

Jul 15, 2026

52W High $2.2152W Low $0.49

Company Details

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refra...

Leadership

Leonard L. Mazur

CEO, President & Executive Chairman

Myron Z. Holubiak

Secretary & Executive Vice Chairman

Myron S. Czuczman M.D.

Executive VP & Chief Medical Officer

Jaime Bartushak

Chief Financial Officer & Treasurer

IPO Date

Dec 8, 2022

Website

\u2014

Key Metrics TTM

Revenue

$6M

- YoY

Net Income

-$43M

EPS (Diluted)

Free Cash Flow

-$17M

Revenue / Share

$0.06

Gross Margin

80.1%

Operating Margin

-775.6%

Net Margin

-757.6%

FCF Margin

-300.4%

P/S

13.1x

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding